Pilot trial of phenylbutyrate in spinal muscular atrophy
- 1 February 2004
- journal article
- clinical trial
- Published by Elsevier in Neuromuscular Disorders
- Vol. 14 (2) , 130-135
- https://doi.org/10.1016/j.nmd.2003.11.006
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The Hammersmith Functional Motor Scale for Children with Spinal Muscular Atrophy: a Scale to Test Ability and Monitor Progress in Children with Limited AmbulationEuropean Journal of Paediatric Neurology, 2003
- Urea cycle disordersCurrent Treatment Options in Neurology, 2003
- Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy: three SMN2 copies fail to rescue some patients from the disease severityZeitschrift für Neurologie, 2002
- Pilot trial of albuterol in spinal muscular atrophyNeurology, 2002
- Reliability of hand‐held dynamometry in spinal muscular atrophyMuscle & Nerve, 2002
- Quantitative Analyses of SMN1 and SMN2 Based on Real-Time LightCycler PCR: Fast and Highly Reliable Carrier Testing and Prediction of Severity of Spinal Muscular AtrophyAmerican Journal of Human Genetics, 2002
- Treatment of spinal muscular atrophy by sodium butyrateProceedings of the National Academy of Sciences, 2001
- Detection of the Survival Motor Neuron (SMN) Genes by FISH: Further Evidence for a Role for SMN2 in the Modulation of Disease Severity in SMA PatientsHuman Molecular Genetics, 1999
- Correlation between severity and SMN protein level in spinal muscular atrophyNature Genetics, 1997
- Natural History in Proximal Spinal Muscular AtrophyArchives of Neurology, 1995